Laura Vertechy

488 total citations
26 papers, 355 citations indexed

About

Laura Vertechy is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Laura Vertechy has authored 26 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Reproductive Medicine, 14 papers in Oncology and 9 papers in Obstetrics and Gynecology. Recurrent topics in Laura Vertechy's work include Ovarian cancer diagnosis and treatment (22 papers), PARP inhibition in cancer therapy (11 papers) and Endometrial and Cervical Cancer Treatments (9 papers). Laura Vertechy is often cited by papers focused on Ovarian cancer diagnosis and treatment (22 papers), PARP inhibition in cancer therapy (11 papers) and Endometrial and Cervical Cancer Treatments (9 papers). Laura Vertechy collaborates with scholars based in Italy and Japan. Laura Vertechy's co-authors include Cláudia Marchetti, Pierluigi Benedetti Panici, Ludovico Muzii, Innocenza Palaia, Federica Tomao, Violante Di Donato, Roberta Iadarola, Angela Musella, Margherita Giorgini and Lavinia Domenici and has published in prestigious journals such as Scientific Reports, Annals of Surgical Oncology and Gynecologic Oncology.

In The Last Decade

Laura Vertechy

23 papers receiving 351 citations

Peers

Laura Vertechy

ONCOL

SURGE

Shu Yao China

Naifu Liu China

Kathrine S Rallis United Kingdom

Kimihiko Ito Japan

Vijaya Galic United States

Shintaro Yanazume Japan

Roberta Iadarola Italy

Yunlang Cai China

Daisuke Aoki Japan

Shu Yao China

Laura Vertechy

70 ×0.5

93 ×0.8

ONCOL

147 ×1.5

110 ×1.6

SURGE

33 ×0.5

Citations per year, relative to Laura Vertechy Laura Vertechy (= 1×) peers Shu Yao

Countries citing papers authored by Laura Vertechy

Since Specialization

Citations

This map shows the geographic impact of Laura Vertechy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Vertechy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Vertechy more than expected).

Fields of papers citing papers by Laura Vertechy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Vertechy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Vertechy. The network helps show where Laura Vertechy may publish in the future.

Co-authorship network of co-authors of Laura Vertechy

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Vertechy. A scholar is included among the top collaborators of Laura Vertechy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Vertechy. Laura Vertechy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vertechy, Laura, Ilary Ruscito, Alessandro Rizzi, et al.. (2025). Platinum-rechallenge in epithelial ovarian cancer relapsing within 6 months after first-line treatment: a propensity score matching analysis. International Journal of Clinical Oncology. 30(9). 1873–1881.

Loverro, Matteo, Vanda Salutari, Diana Giannarelli, et al.. (2025). Real-world outcomes of PARP inhibitor maintenance in advanced ovarian cancer: a focus on disease patterns and treatment modalities at recurrence. ESMO Open. 10(2). 104119–104119.

Boccia, Serena Maria, Ilary Ruscito, Laura Vertechy, et al.. (2025). Association Between BRCA1 And BRCA2 Mutations With Toxicity From Olaparib In Platinum Sensitive Relapsed High Grade Ovarian Cancer. International Journal of Gynecological Cancer. 35(2). 100099–100099.

Boccia, Serena Maria, Laura Vertechy, Eleonora Palluzzi, et al.. (2024). Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?. Drug Design Development and Therapy. Volume 18. 2021–2032. 3 indexed citations

Fagotti, Anna, Chiara Cassani, Lorena Incorvaia, et al.. (2023). 42P Efficacy of maintenance with PARPi in advanced ovarian cancer according to the location of BRCA mutation. ESMO Open. 8(1). 100822–100822. 1 indexed citations

Marchetti, Cláudia, Anna Fagotti, Robert Fruscio, et al.. (2023). #765 Efficacy of maintenance with PARPi in advanced ovarian cancer according to the type of BRCA mutation. A26–A26. 1 indexed citations

Vertechy, Laura, Serena Maria Boccia, Giacomo Avesani, et al.. (2022). Trabectedin plus pegylated liposomal doxorubicin in patients with disease progression after PARP inhibitor maintenance: a real-life case–control study. International Journal of Gynecological Cancer. 33(2). 243–249. 5 indexed citations

Marchetti, Cláudia, Martina Arcieri, Laura Vertechy, et al.. (2022). Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study. European Journal of Surgical Oncology. 48(12). 2539–2544. 5 indexed citations

Palluzzi, Eleonora, Giacomo Corrado, Cláudia Marchetti, et al.. (2021). Medical treatment of patients with gynecologic cancer during the COVID-19 pandemic. International Journal of Gynecological Cancer. 31(8). 1154–1158. 1 indexed citations

10.

Marchetti, Cláudia, Marco D’Indinosante, Carolina Bottoni, et al.. (2021). NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer. Scientific Reports. 11(1). 11125–11125. 17 indexed citations

11.

Marchetti, Cláudia, Andrea Rosati, Francesca De Felice, et al.. (2021). Optimizing the number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma: A propensity-score matching analysis. Gynecologic Oncology. 163(1). 29–35. 15 indexed citations

12.

Lorusso, Domenica, Cláudia Marchetti, Carmine Conte, et al.. (2020). Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study. Gynecologic Oncology. 159(1). 95–100. 5 indexed citations

13.

Musella, Angela, Erlisa Bardhi, Cláudia Marchetti, et al.. (2018). Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer. Cancer Treatment Reviews. 66. 7–14. 50 indexed citations

14.

Marchetti, Cláudia, Angela Musella, Alessia Romito, et al.. (2017). Short-Infusion Trabectedin in Heavily Pretreated Ovarian Cancer Patients: A Single-Institution Experience. Oncology. 93(6). 359–366. 2 indexed citations

15.

Marchetti, Cláudia, Innocenza Palaia, Francesca De Felice, et al.. (2015). Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients. Cancer Treatment Reviews. 42. 41–46. 13 indexed citations

16.

Panici, Pierluigi Benedetti, Innocenza Palaia, Cláudia Marchetti, et al.. (2015). Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study. Oncology. 89(2). 103–110. 23 indexed citations

17.

Imperiale, Ludovica, Cláudia Marchetti, Roberta Iadarola, et al.. (2014). Nonabsorbable suture granuloma mimicking ovarian cancer recurrence at combined positron emission tomography/computed tomography evaluation: a case report. Journal of Medical Case Reports. 8(1). 202–202. 8 indexed citations

18.

Panici, Pierluigi Benedetti, Cláudia Marchetti, Angela Musella, et al.. (2014). Dualistic Classification of Epithelial Ovarian Cancer: Surgical and Survival Outcomes in a Large Retrospective Series. Annals of Surgical Oncology. 21(9). 3036–3041. 11 indexed citations

19.

Marchetti, Cláudia, Margherita Giorgini, Innocenza Palaia, et al.. (2014). Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review. OncoTargets and Therapy. 7. 1223–1223. 116 indexed citations

20.

Marchetti, Cláudia, et al.. (2013). An Unexpected Complete Remission of Advanced Intestinal-Type Vulvar Adenocarcinoma after Neoadjuvant Chemotherapy: A Case Report and a Literature Review. Case Reports in Obstetrics and Gynecology. 2013. 1–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact